These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 5834684)

  • 1. [Indications for a monoamine oxidase inhibitor hydrazine (nialamide) in the treatment of asthenic and hypochondriac neuroses. (Apropos of 70 ambulatory treatments)].
    Leyrie J
    Ann Med Psychol (Paris); 1965 May; 123(5):745-9. PubMed ID: 5834684
    [No Abstract]   [Full Text] [Related]  

  • 2. [Are the MAOIs outmoded?].
    Van Renynghe G
    Acta Psychiatr Belg; 1972 Nov; 72(6):767-88. PubMed ID: 4679553
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical dynamics of hypochondriacal disorders and mechanisms of their reversal during psychotherapy].
    Kalachev BP; Darenskiĭ ID
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1983; 83(11):1716-20. PubMed ID: 6675376
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Anabolic action of the monoamine oxidase inhibitors. Use of "Nialamide" in the treatment of women with decision and neurosis "deficit"].
    Procópio-Valle J
    Hospital (Rio J); 1968 Feb; 73(2):649-53. PubMed ID: 5311364
    [No Abstract]   [Full Text] [Related]  

  • 5. [Protracted neuroses of asthenic type in children and adolescents].
    Lobikova NA
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1971; 71(10):1524-8. PubMed ID: 5139415
    [No Abstract]   [Full Text] [Related]  

  • 6. [Experiences in the use of SD 709 in the depressive syndrome].
    Guth E; Hoffmann G
    Wien Klin Wochenschr; 1966 Jan; 78(1):14-6. PubMed ID: 5962851
    [No Abstract]   [Full Text] [Related]  

  • 7. [INITIATION OF ACTION OF THE MAO-INHIBITOR NIAMIDE IN DEPRESSION].
    RADMAYR E
    Wien Med Wochenschr; 1964 Feb; 114():136-8. PubMed ID: 14137333
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of nialamide, a monoamine oxidase inhibitor, on acetylcholine-adrenaline induced atrial fibrillation in normal & reserpinized dogs.
    Stephen PM
    Indian J Exp Biol; 1974 Nov; 12(6):499-503. PubMed ID: 4464251
    [No Abstract]   [Full Text] [Related]  

  • 9. [Asthenic states and one of their modern treatments].
    Bugard P
    Therapeutique; 1972 Apr; 48(4):297-302. PubMed ID: 5073101
    [No Abstract]   [Full Text] [Related]  

  • 10. [Tolerance to monoamine oxidase inhibitors. A case report of tolerance of nialamide and moclobemide].
    Reine G; Llorca PM; Bougerol T
    Encephale; 1993; 19(6):663. PubMed ID: 12404787
    [No Abstract]   [Full Text] [Related]  

  • 11. [Comparative study of the clinical dynamics of neuroses with variable expression of the hypochondriacal syndrome].
    Kalachev BP; Lakosina ND; Darenskiĭ ID
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1984; 84(11):1679-83. PubMed ID: 6524188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The treatment of depressive conditions using nialamide infusions].
    Misurec J; Bojanovský J; Chloupková K
    Cesk Psychiatr; 1966 Apr; 62(2):114-8. PubMed ID: 5930847
    [No Abstract]   [Full Text] [Related]  

  • 13. Treatment of depressive states with infusions of Nialamide.
    Misurec J; Bojanovský J; Chloupková K
    Act Nerv Super (Praha); 1965 Aug; 7(3):294-5. PubMed ID: 5883125
    [No Abstract]   [Full Text] [Related]  

  • 14. [Fasting-diet therapy combined with psychotherapy in hypochondriac conditions of neurotic etiology].
    Lipsart NK; Terenkovskiĭ DI
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1990; 90(3):91-5. PubMed ID: 2163179
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Experience with the therapeutic use of grandaxin in neuroses].
    Kostiunina ZG; Eletskiĭ VIu
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1982; 82(4):117-20. PubMed ID: 6124072
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Psychopathological significance of somatic symptoms in hypochondriac states].
    Vianu I
    Neurol Psihiatr Neurochir; 1970; 15(5):445-56. PubMed ID: 5492054
    [No Abstract]   [Full Text] [Related]  

  • 17. [Dangers of a too rapid substitution of imipramine for an inhibitor of monoamine oxidase and of the nialamide-isoniazid-barbiturate combination at high doses in psychiatric therapy].
    Guilmot P; Rucquoy G
    Acta Neurol Psychiatr Belg; 1967 Mar; 67(3):159-71. PubMed ID: 4962435
    [No Abstract]   [Full Text] [Related]  

  • 18. [Effects of inhibitors of monoamine oxidase on sleep and the electroencephalogram in man].
    Cramer H; Kuhlo W
    Acta Neurol Psychiatr Belg; 1967 Aug; 67(8):658-69. PubMed ID: 4964900
    [No Abstract]   [Full Text] [Related]  

  • 19. [Clinical trial of neuropton (nialamide-hydroxyzine pamoate)].
    Bourgeois M
    Ann Med Psychol (Paris); 1970 Jan; 1(1):134-8. PubMed ID: 5421306
    [No Abstract]   [Full Text] [Related]  

  • 20. [Delta-aminolevulinic-dehydrase and delta-aminolevulinic-oxidase activity in subjects treated with nialamide].
    Pisani W; Bonzanino A; Fiandaca G
    Boll Soc Ital Biol Sper; 1968 Dec; 44(23):2069-71. PubMed ID: 5735787
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.